The mastomys rodent exhibits a genetic propensity to develop gastric c
arcinoid tumors. Utilizing acid inhibitory pharmacotherapy (histamine-
2 receptor antagonists and proton pump inhibitors), we have demonstrat
ed transformation from normal to neoplastic enterochromaffin-like (ECL
) cells in a well-defined fashion over a period of 4 months. In additi
on, we have demonstrated inhibition of tumor growth with either somato
statin or histamine-1 receptor antagonists (terfenadine and cyprohepta
dine). In order to define the regulation of growth and secretion of tr
ansformed ECL cells, we developed an isolated pure ECL cell system. EC
L cells secrete histamine in response to gastrinergic (gastrin), musca
rinic (carbachol), and a-adrenergic (isoproterenol) stimulation. Both
cAMP and intracellular calcium-dependent mechanisms are involved in th
e process of histamine secretion.